Anti-angiogenesis agent

This page covers all Anti-angiogenesis agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting VEGF.

Targets

VEGF

Phase 1 pipeline (1)

• Anti-angiogenesis · Amgen · Oncology
  Inhibits angiogenesis by targeting vascular endothelial growth factor (VEGF)